Learn More
Apexbio Technology LLC AMG-208 1002304-34-8 5mg

Supplier: Apexbio Technology LLC A11865
AMG-208 (CAS 1002304-34-8) is a highly selective small molecule inhibitor of the receptor tyrosine kinase c-Met which is the endogenous receptor for hepatocyte growth factor (HGF) and is involved in cellular processes such as proliferation migration and invasion AMG-208 exhibits potent c-Met inhibition with an IC50 of 9 3 nM in enzymatic assays and effectively blocks HGF-induced c-Met phosphorylation in PC3 cells with an IC50 of 46 nM In human liver microsome studies AMG-208 showed time-dependent inhibition of CYP3A4 activity Pharmacokinetic evaluation in rats demonstrated high bioavailability and a moderate elimination half-life Dysregulation of c-Met has been implicated in multiple human cancers supporting AMG-208 s utility as a research tool in oncology
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.